Search Ontology:
ChEBI

beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-OH

Term ID
CHEBI:147585
Synonyms
  • beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactitol
  • beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-ol
  • N-[(2R,3R,4R,5S,6R)-2-[(2S,3R,4S,5R)-2-acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
Definition
A glycosyl alditol derivative consisting of β-D-galactopyranose, 2-acetamido-2-deoxy-β-D-glucopyranose and N-acetyl-D-galactosaminitol residues joined in sequence by (1→3) glycosidic bonds.
References
  • glygen:G14191ZT
  • glytoucan:G14191ZT
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-OH
Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-OH
Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-OH
Phenotype affecting beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-D-GalNAc-OH
Human Disease Model